CIK 0001770069
- Emerging growth company
MapLight Therapeutics, Inc.
Sign in to watch- Ticker
- MPLT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 832163243
- Phone
- +1 617-984-6300
- Business address
- 800 CHESAPEAKE DRIVE, REDWOOD CITY, CA, 94063
- Former names
- Alvarado Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,256,232
- in 7 filings, $193K under 10b5-1 plans
Net −$1,256,232. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Kroeger Christopher A. −$595K Chief Executive Officer sold 6% of stake
- Hanson Kristopher −$266K General Counsel sold 17% of stake
- Foff Erin Pennock −$124K Chief Medical Officer sold 5% of stake
- Kreitzer Anatol −$96K Chief Discovery Officer sold 7% of stake
- Lillie James Woodruff −$93K Chief Scientific Officer sold 5% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-06 | Setia Vishwas Chief Financial Officer | Sale 10b5-1 | −8,496 | $28.04 | $238K | 358,324 |
| 2026-05-06 | Setia Vishwas Chief Financial Officer | Sale 10b5-1 | −2,068 | $29.07 | $60K | 356,256 |
| 2026-05-05 | Setia Vishwas Chief Financial Officer | Sale 10b5-1 | −9,935 | $28.12 | $279K | 367,788 |
| 2026-05-05 | Setia Vishwas Chief Financial Officer | Sale 10b5-1 | −968 | $29.00 | $28K | 366,820 |
| 2026-05-04 | Setia Vishwas Chief Financial Officer | Sale 10b5-1 | −4,803 | $27.36 | $131K | 387,824 |
| 2026-05-04 | Setia Vishwas Chief Financial Officer | Sale 10b5-1 | −8,989 | $28.28 | $254K | 378,835 |
| 2026-05-04 | Setia Vishwas Chief Financial Officer | Sale 10b5-1 | −325 | $29.56 | $10K | 378,510 |
| 2026-05-04 | Setia Vishwas Chief Financial Officer | Sale 10b5-1 | −787 | $30.12 | $24K | 377,723 |
| 2026-04-16 | Setia Vishwas Chief Financial Officer | Sale | −29 | $27.01 | $783 | 392,714 |
| 2026-04-16 | Setia Vishwas Chief Financial Officer | Sale | −87 | $27.49 | $2K | 392,627 |
| 2026-04-15 | Setia Vishwas Chief Financial Officer | Sale | −2,806 | $26.87 | $75K | 392,743 |
| 2026-02-05 | Setia Vishwas Chief Financial Officer | Grant or award | +7,730 | 395,549 | ||
| 2026-02-05 | Setia Vishwas Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +31,395 | 31,395 | ||
| 2026-01-27 | Setia Vishwas Chief Financial Officer | Shares withheld for taxes | −33,382 | $17.98 | $600K | 387,819 |
| 2025-10-27 | Setia Vishwas Chief Financial Officer | Grant or award | +43,367 | 43,367 | ||
| 2025-10-27 | Setia Vishwas Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +176,031 | 176,031 |
Page 1 of 1 · 16 trades